Diagnostic performance of thallium-201 dipyridamole myocardial scintigraphy for the detection of coronary heart disease

Citation
P. Poret et al., Diagnostic performance of thallium-201 dipyridamole myocardial scintigraphy for the detection of coronary heart disease, PRESSE MED, 28(16), 1999, pp. 829-834
Citations number
19
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
PRESSE MEDICALE
ISSN journal
07554982 → ACNP
Volume
28
Issue
16
Year of publication
1999
Pages
829 - 834
Database
ISI
SICI code
0755-4982(19990424)28:16<829:DPOTDM>2.0.ZU;2-2
Abstract
OBJECTIVES: Determine the diagnostic performance of thallium-201 myocardial scintigraphy using dipyridamole injection for the detection of coronary he art disease (myocardial ischemia and/or necrosis). Determine for each coron ary artery the degree of angiographic stenosis for optimal diagnostic perfo rmance. PATIENTS AND METHODS :The study included 309 patients who underwent coronar ography within 6 months of the scintigraphy examination None of the patient s experienced a coronary event during this interval. Diagnostic performance of the scintigraphic exploration was compared with angiographic findings ( stenosis 70%) used as the gold standard. The degree of angiographic stenosi s for optimal scintigraphic performance was determined from the receiver op erating characteristic (ROC) curves. RESULTS :The sensitivity of scintigraphy to detect angiographically demonst rated coronary disease was 84% with a specificity of 72%. The positive and negative predictive values were 87% and 66% respectively Test accuracy was 80%. Sensitivity was better for detecting lesions of the anterior intervent ricular coronary than for the right coronary or circumflex. In addition, se nsitivity varied with the number of vessels involved: 76% for single-vessel disease venus 90% for two- or three-vessel disease. The data analysis also suggested that an angiographic stenosis threshold of 50% provided optimal predictive value for scintigraphy for each of the three vessel territories. An analysis based on maximal stenosis in each patient, notwithstanding the congruency between Lesion localization and diseased vessel territories, wa s found to provide less diagnostic precision. CONCLUSION: Thallium-201 dipyridamole myocardial scintigraphy offers diagno stic performance comparable to that established with thallium-201 scintigra phy performed after exercise alone. Scintigraphic detection of a perfusion defect generally corresponds to an angiographic stenosis of 50%.